Mirae Asset Global Investments Co., Ltd. Ascendis Pharma A/S Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,216 shares of ASND stock, worth $979,593. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,216
Previous 13,276
38.11%
Holding current value
$979,593
Previous $2.01 Million
44.17%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.21 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$592 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$512 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$500 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$467 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.65B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...